首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1902342

整形外科生物製劑市場規模、佔有率及成長分析（按產品類型、應用、最終用戶和地區分類）－2026-2033年產業預測

Orthobiologics Market Size, Share, and Growth Analysis, By Product Type (Demineralized Bone Matrix (DBM), Allograft), By Type (Knee, Ankle), By Application, By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球整形外科生物製劑市場規模將達到 64.3 億美元，到 2025 年將達到 67.8 億美元，到 2033 年將達到 104.1 億美元，預測期（2026-2033 年）的複合年成長率為 5.5%。

全球整形外科生物製劑市場涵蓋多種旨在促進肌肉骨骼疾病和損傷癒合的產品，包括幹細胞、骨移植和富血小板血漿（PRP）療法。再生醫學的進步、人口老化以及整形外科手術量的增加是推動市場成長的主要因素。然而，嚴格的監管核准、缺乏標準化以及不斷上漲的治療成本等挑戰可能會阻礙市場發展。儘管存在這些障礙，但整形外科生物製劑應用範圍的擴大、研究活動的增加以及對個人化醫療日益成長的關注等機遇，預計將推動市場顯著成長。這種成長潛力凸顯了創新和可近性在解決肌肉骨骼健康問題的重要性。

推動全球整形外科生物製劑市場發展的因素

全球整形外科生物製劑市場的成長主要得益於技術進步和持續的研發活動。富血小板血漿（PRP）和幹細胞療法等治療方法創新，以及各種相關技術，正在提高整形外科生物製劑的可及性、可用性和有效性。這些進展不僅促進了新治療方案和產品的推出，還有助於改善癒合過程和整體復健效果。因此，這些現代化方法和治療方法的不斷發展正對市場產生積極影響。

全球整形外科生物製劑市場限制因素

全球整形外科生物製劑市場的發展受到許多因素的限制，包括需要進行大量研究以及各種治療方法療效差異較大。儘管該領域存在進步和創新的潛力，但檢驗特定整形外科生物製劑療效的臨床研究深度不足，可能會限制醫療機構對其的接受度。此外，不同研究報告的結果不一致，可能導致人們對某些產品的療效產生懷疑，最終影響其在臨床實務中的應用。缺乏確鑿的證據阻礙了整形外科生物製劑的廣泛應用和公眾信任，而骨科生物製劑對於再生醫學治療至關重要。

全球整形外科生物製劑市場趨勢

全球整形外科生物製劑市場呈現強勁成長趨勢，這主要得益於富血小板血漿（PRP）療法在治療各種肌肉骨骼疾病（包括關節疼痛、軟組織損傷和術後復健）方面的應用日益廣泛。隨著醫療專業人員認知到PRP療法在加速癒合過程中的潛在益處，這種再生醫學方法正變得越來越普及。此外，PRP製備和給藥通訊協定的標準化工作也在不斷推進，這提高了治療方法的可靠性，從而增強了治療的可重複性和療效。因此，整形外科生物製劑產業有望迎來顯著成長，並受益於能夠改善治療效果和提升患者滿意度的各項技術進步。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Stryker Corporation（USA）
Medtronic plc（Ireland）
Zimmer Biomet Holdings, Inc.（USA）
DePuy Synthes（Johnson & Johnson）（USA）
Bioventus LLC（USA）
Arthrex, Inc.（USA）
NuVasive, Inc.（USA）
Orthofix International NV（Netherlands）
Globus Medical, Inc.（USA）
Kuros Biosciences AG（Switzerland）
Xtant Medical Holdings, Inc.（USA）
Harvest Technologies Corporation（USA）
Wright Medical Group NV（Netherlands）
Smith & Nephew plc（UK）
Bone Biologics Corp.（USA）
Sano Orthopedics（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2070

Global Orthobiologics Market size was valued at USD 6.43 Billion in 2024 and is poised to grow from USD 6.78 Billion in 2025 to USD 10.41 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The global orthobiologics market encompasses a diverse array of products designed to enhance the healing of musculoskeletal conditions and injuries, including stem cells, bone grafts, and PRP (platelet-rich plasma) therapies. Market growth is driven by advancements in regenerative medicine, an aging population, and an increase in orthopedic procedures. However, challenges such as stringent regulatory approvals, a lack of standardization, and high treatment costs may hinder progress. Despite these obstacles, the market is poised for significant expansion, supported by opportunities arising from broader applications of orthobiologics, increased research initiatives, and a growing focus on personalized medicine. This potential for growth underscores the importance of innovation and accessibility in addressing musculoskeletal health issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segments Analysis

Global Orthobiologics Market is segmented by Product Type, Type, Application, End-user and region. Based on Product Type, the market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone morphogenetic protein (BMP), Viscosupplementation, Synthetic bone substitutes and Stem cell therapy. Based on Type, the market is segmented into Knee, Ankle, Hip, Wrist & Shoulder, Spine and Others. Based on Application, the market is segmented into Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications. Based on End-user, the market is segmented into Hospitals & Ambulatory Centers, Research & Academic Institute and Dental Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Orthobiologics Market

The growth of the global orthobiologics market is significantly driven by advancements in technology and ongoing research and development efforts. Innovations in therapies such as platelet-rich plasma (PRP) and stem cell treatments, along with various related techniques, are enhancing the accessibility, availability, and effectiveness of orthobiologics. These developments are not only facilitating the introduction of new treatment options and products but also contributing to improved healing processes and overall recovery outcomes. As a result, the market is experiencing a positive impact from these modernized approaches and the continuous evolution of therapeutic modalities.

Restraints in the Global Orthobiologics Market

The Global Orthobiologics market is significantly hindered by the demand for extensive research and the variability of outcomes associated with various therapies. Although advancements and innovations hold potential, the insufficient depth of clinical research that validates the efficacy of certain orthobiologics can limit their acceptance among healthcare providers. Additionally, inconsistent findings across studies may foster skepticism regarding the effectiveness of specific products, ultimately impacting their adoption in clinical practice. This lack of conclusive evidence creates a barrier, preventing widespread utilization and confidence in orthobiologics, which are vital for treatment in regenerative medicine.

Market Trends of the Global Orthobiologics Market

The Global Orthobiologics market is witnessing a robust upward trend, driven by the increasing adoption of Platelet-Rich Plasma (PRP) treatments for various musculoskeletal conditions, including joint pain, soft tissue injuries, and post-surgical recovery. This regenerative approach is becoming more prevalent as healthcare professionals recognize its potential benefits in enhancing healing processes. Additionally, ongoing efforts to standardize PRP preparation and administration protocols are fostering greater confidence in these therapies, thereby improving their reproducibility and efficacy. As a result, the orthobiologics sector is positioning itself for significant growth, capitalizing on advancements that enhance treatment outcomes and patient satisfaction.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Orthobiologics Market Size by Product Type & CAGR (2026-2033)

Market Overview
Demineralized Bone Matrix (DBM)
Allograft
Bone morphogenetic protein (BMP)
Viscosupplementation
Synthetic bone substitutes
Stem cell therapy

Global Orthobiologics Market Size by Type & CAGR (2026-2033)

Market Overview
Knee
Ankle
Hip
Wrist & Shoulder
Spine
Others

Global Orthobiologics Market Size by Application & CAGR (2026-2033)

Market Overview
Osteoarthritis & Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial & Dental Applications

Global Orthobiologics Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals & Ambulatory Centers
Research & Academic Institute
Dental Clinics

Global Orthobiologics Market Size & CAGR (2026-2033)

North America (Product Type, Type, Application, End-user)
- US
- Canada
Europe (Product Type, Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes (Johnson & Johnson) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVasive, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix International N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Globus Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuros Biosciences AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xtant Medical Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Harvest Technologies Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Medical Group N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bone Biologics Corp. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sano Orthopedics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments